Filing Details
- Accession Number:
- 0001104659-19-076291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-27 07:01:42
- Reporting Period:
- 2019-12-24
- Accepted Time:
- 2019-12-27 07:01:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1137883 | Brainstorm Cell Therapeutics Inc. | BCLI | Biological Products, (No Disgnostic Substances) (2836) | 207273918 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1699684 | Dr. Ralph Kern | C/O Brainstorm Cell Therapeutics, Inc. 1325 Avenue Of Americas, 28Th Floor New York NY 10019 | Coo And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-24 | 3,000 | $3.88 | 115,655 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
